Literature DB >> 31085523

Chronic Opioid Prescribing in Primary Care: Factors and Perspectives.

Sebastian T Tong1, Camille J Hochheimer2, E Marshall Brooks2, Roy T Sabo2, Vivian Jiang2, Teresa Day2, Julia S Rozman2, Paulette Lail Kashiri2, Alex H Krist2.   

Abstract

BACKGROUND: Primary care clinicians write 45% of all opioid prescriptions in the United States, but little is known about the characteristics of patients who receive them and the clinicians who prescribe opioids in primary care settings. Our study aimed to describe the patient and clinician characteristics and clinicians' perspectives of chronic opioid prescribing in primary care.
METHODS: Using a mixed methods approach, we completed an analysis of 2016 electronic health records from 21 primary care practices to identify patients who had received chronic opioids, which we defined as in receipt of an opioid prescription for at least 3 consecutive months. We compared those receiving chronic opioids with those not in terms of their demographics, prescribing clinician characteristics, and risk factors for opioid-related harms, as identified by the Centers for Disease Control and Prevention Guideline on Opioid Prescribing for Chronic Pain. We then interviewed 16 primary care clinicians about their perspectives on chronic opioid prescribing.
RESULTS: Of 84,029 patients, 1.1% (902/84,929) received chronic opioid prescriptions. Characteristics associated with being prescribed chronic opioids include being female, being of black or African American race, and having risks for opioid-related harms, such as mental health diagnoses, substance use disorder, and concurrent benzodiazepine use. Clinicians report multiple difficulties in weaning patients from chronic opioids, including medical contraindications of nonopioid alternatives and difficulty justifying weaning by stable long-term patients.
CONCLUSION: Although patients prescribed opioids in primary care have higher risks of opioid-related harms, clinicians report multiple barriers in deprescribing chronic opioids. Future studies should examine strategies to mitigate these harms and engage patients in shared decision making about their chronic opioid use.
© 2019 Annals of Family Medicine, Inc.

Entities:  

Keywords:  opiates; prescription drugs; primary care physicians

Mesh:

Substances:

Year:  2019        PMID: 31085523      PMCID: PMC6827634          DOI: 10.1370/afm.2357

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  21 in total

1.  Distribution of Opioids by Different Types of Medicare Prescribers.

Authors:  Jonathan H Chen; Keith Humphreys; Nigam H Shah; Anna Lembke
Journal:  JAMA Intern Med       Date:  2016-02       Impact factor: 21.873

2.  Primary care provider concerns about management of chronic pain in community clinic populations.

Authors:  Carole C Upshur; Roger S Luckmann; Judith A Savageau
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

3.  Geographic and specialty distribution of US physicians trained to treat opioid use disorder.

Authors:  Roger A Rosenblatt; C Holly A Andrilla; Mary Catlin; Eric H Larson
Journal:  Ann Fam Med       Date:  2015 Jan-Feb       Impact factor: 5.166

4.  Weighing the Risks and Benefits of Chronic Opioid Therapy.

Authors:  Anna Lembke; Keith Humphreys; Jordan Newmark
Journal:  Am Fam Physician       Date:  2016-06-15       Impact factor: 3.292

5.  Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study.

Authors:  Luke Mordecai; Carl Reynolds; Liam J Donaldson; Amanda C de C Williams
Journal:  Br J Gen Pract       Date:  2018-02-12       Impact factor: 5.386

Review 6.  Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders.

Authors:  N S Miller; L M Sheppard; C C Colenda; J Magen
Journal:  Acad Med       Date:  2001-05       Impact factor: 6.893

7.  Changes in trends and pattern of strong opioid prescribing in primary care.

Authors:  C S Zin; L C Chen; R D Knaggs
Journal:  Eur J Pain       Date:  2014-04-22       Impact factor: 3.931

8.  Opioid prescribing patterns for non-malignant chronic pain for rural versus non-rural US adults: a population-based study using 2010 NAMCS data.

Authors:  Jacob P Prunuske; Catherine A St Hill; Keri D Hager; Andrine M Lemieux; Michael T Swanoski; Grant W Anderson; M Nawal Lutfiyya
Journal:  BMC Health Serv Res       Date:  2014-11-19       Impact factor: 2.655

9.  Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.

Authors:  Puja Seth; Lawrence Scholl; Rose A Rudd; Sarah Bacon
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-30       Impact factor: 17.586

Review 10.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

View more
  14 in total

1.  Coprescribing of opioids and high-risk medications in the USA: a cross-sectional study with data from national ambulatory and emergency department settings.

Authors:  Kara Suvada; Anna Zimmer; Jesse Soodalter; Jimi S Malik; Dio Kavalieratos; Mohammed K Ali
Journal:  BMJ Open       Date:  2022-06-16       Impact factor: 3.006

2.  The protocol of the Application of Economics & Social psychology to improve Opioid Prescribing Safety Trial 1 (AESOPS-1): Electronic health record nudges.

Authors:  Marcella A Kelley; Stephen D Persell; Jeffrey A Linder; Mark W Friedberg; Daniella Meeker; Craig R Fox; Noah J Goldstein; Tara K Knight; Dina Zein; Theresa A Rowe; Mark D Sullivan; Jason N Doctor
Journal:  Contemp Clin Trials       Date:  2021-02-24       Impact factor: 2.226

3.  Low Back Pain and Substance Use: Diagnostic and Administrative Coding for Opioid Use and Dependence Increased in U.S. Older Adults with Low Back Pain.

Authors:  Beth B Hogans; Bernadette C Siaton; Michelle N Taylor; Leslie I Katzel; John D Sorkin
Journal:  Pain Med       Date:  2021-04-20       Impact factor: 3.750

4.  Cross Disciplinary Role Agreement is Needed When Coordinating Long-Term Opioid Prescribing for Cancer: a Qualitative Study.

Authors:  K F Giannitrapani; M J Silveira; A Azarfar; P A Glassman; S J Singer; S M Asch; A M Midboe; M A Zenoni; R C Gamboa; W C Becker; K A Lorenz
Journal:  J Gen Intern Med       Date:  2021-05-04       Impact factor: 6.473

5.  Development and Performance of a Web-Based Tool to Adjust Urine Toxicology Testing Frequency: Retrospective Study.

Authors:  Kenneth B Chapman; Martijn M Pas; Diana Abrar; Wesley Day; Kris C Vissers; Noud van Helmond
Journal:  JMIR Med Inform       Date:  2020-04-22

6.  Launching a Medication-Assisted Treatment in an Outpatient Office-Based Practice.

Authors:  Julienne K Kirk; Tamela Yount; Charlotte T Boyd; Lisa Cassidy-Vu; Aubry N Koehler; John G Spangler
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

7.  The Risk of Prior Opioid Exposure on Future Opioid Use and Comorbidities in Individuals With Non-Acute Musculoskeletal Knee Pain.

Authors:  Daniel I Rhon; Suzanne J Snodgrass; Joshua A Cleland; Chad E Cook
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

8.  Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter.

Authors:  Jose Vladimir Sandoval-Sierra; Francisco I Salgado García; Jeffrey H Brooks; Karen J Derefinko; Khyobeni Mozhui
Journal:  Clin Epigenetics       Date:  2020-06-03       Impact factor: 6.551

9.  Reducing Opioid Overprescribing by Educating, Monitoring and Collaborating with Clinicians: A Quality Improvement Study.

Authors:  Avni Gupta; Stephanie Lindstrom; Gauri Shevatekar
Journal:  Cureus       Date:  2020-04-22

Review 10.  Applying the NIA Health Disparities Research Framework to Identify Needs and Opportunities in Chronic Musculoskeletal Pain Research.

Authors:  Monika Patel; Alisa J Johnson; Staja Q Booker; Emily J Bartley; Shreela Palit; Keesha Powell-Roach; Ellen L Terry; Dottington Fullwood; Lucas DeMonte; Angela M Mickle; Kimberly T Sibille
Journal:  J Pain       Date:  2021-07-17       Impact factor: 5.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.